Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.09USD
29 May 2015
Change (% chg)

$0.00 (+4.40%)
Prev Close
$0.09
Open
$0.09
Day's High
$0.09
Day's Low
$0.09
Volume
194,000
Avg. Vol
420,532
52-wk High
$0.55
52-wk Low
$0.07

GTHP.OB

Chart for GTHP.OB

About

Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. The Company’s technology,... (more)
No analyst recommendations are available for GTHP.OB.

Overall

Beta: 0.51
Market Cap(Mil.): $10.15
Shares Outstanding(Mil.): 106.83
Dividend: --
Yield (%): --

Financials

  GTHP.OB Industry Sector
P/E (TTM): -- 17.79 39.28
EPS (TTM): -0.12 -- --
ROI: -- 3.11 15.64
ROE: -- 3.52 16.64
Search Stocks

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $60.89 +1.19
GlaxoSmithKline plc (GSK.L) 1,453.50p -6.50
Hologic, Inc. (HOLX.OQ) $35.77 +0.48
Qiagen NV (QGEN.OQ) $24.57 -0.32
SpectraScience Inc (SCIE.PK) $0.02 +0.00

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks